Arkolith/Insider Trading/ORKA/Form 4

Agarwal Arjun

Senior Vice President, FinanceOruka Therapeutics, Inc. (ORKA) · full profile →Form 4 · filed May 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$608K
Net Open-Market Flow
-$608K
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 18, 2026Option exercise(M)2K$12.50$25K21K
May 18, 2026Option exercise(M)6K$34.39$201K27K
May 18, 2026Sell(S)4K$58.34$244K23K
May 18, 2026Sell(S)5K$59.19$272K18K
May 18, 2026Sell(S)800$60.34$48K17K
May 18, 2026Sell(S)700$61.16$43K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 18, 2026Option exercise(M)2K—$0118K
May 18, 2026Option exercise(M)6K—$064K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000041) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML